Data were collected from a 20-week pilot trial (NCT05786521), which randomized 20 older adults (72.7 4.8 years of age, 50% women, 45% Hispanic) living with prediabetes/diabetes (hemoglobin A1C 5.7%7.5%) and overweight/obesity [body mass index (BMI): 32.9 4.0 kg/m 2 ] to 1.0 mg/weekly semaglutide + lifestyle counseling (n = 10) or lifestyle counseling alone (n = 10)
They reflect investor conviction that the $190 billion opportunity lies in serving intentional, nutrient-dense consumption, not traditional snacking
Zepbound should not be used with other products containing tirzepatide or any other GLP-1 receptor agonists, and it has not been studied in patients with a history of pancreatitis
Results vary, but studies show that individuals using Semaglutide for weight loss can lose an average of 10-15% of their body weight over time
Subcutaneous delivery places the drug in the hypodermis, where it absorbs gradually and holds steadier concentrations